Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation

Amyloid precursor protein (APP), upon proteolytic degradation, forms aggregates of amyloid β (Aβ) and plaques in the brain, which are pathological hallmarks of Alzheimer’s disease (AD). Cathepsin B is a cysteine protease enzyme that catalyzes the proteolytic degradation of APP in the brain. Thus, ca...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Nitin Chitranshi, Ashutosh Kumar, Samran Sheriff, Veer Gupta, Angela Godinez, Danit Saks, Soumalya Sarkar, Ting Shen, Mehdi Mirzaei, Devaraj Basavarajappa, Morteza Abyadeh, Sachin K. Singh, Kamal Dua, Kam Y. J. Zhang, Stuart L. Graham, Vivek Gupta
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-07-01
Saila:	Cells
Gaiak:	Alzheimer’s disease cathepsin B 3D pharmacophore virtual screening docking molecular dynamics
Sarrera elektronikoa:	https://www.mdpi.com/2073-4409/10/8/1946
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!